ArticleCancer chemotherapy and pharmacology2026

Selpercatinib-induced renal tubular damage resulting in symptomatic hyponatremia and polyuria: a case report.

Lyan Betsema et al.PubMed ↗Publisher ↗

No numbers read from the abstract.